Biomarker Testing Market 2022 Key Players and Production Information Analysis with Forecast 2028 | Agilent Technologies, Roche

The "Biomarker Testing Market" report describes in detail the demand and consumption of various products related to the market growth dynamics during the forecast period of 2022-2028. A detailed market assessment of the various opportunities in the market segment is expressed in terms of quantity. These are discussed in many sections, including constraints, challenges and opportunities, regional breakdown and opportunity assessment. This global Biomarker Testing Market report guarantees rich data on various market opportunities. The research report covers key gaming enthusiasts within the industry, CAGR value, market drivers, restraints, and international competitive strategies from the region.  The report includes strong research from expert analysts.

The global Biomarker Testing Market is expected to grow with a CAGR greater than 14.3% during the forecast period of 2022-2028.

(Exclusive Offer: Flat 25% discount on this report)

Get a sample report with the latest industry trend analysis:

https://www.marketintelligencedata.com/reports/4681565/global-biomarker-testing-market-insights-and-forecast-to-2028/inquiry?mode=Snehal

Market Overview:

The global biomarkers market size was valued at USD 51.18 billion in 2020. The increasing prevalence of chronic diseases, advancements in the techniques used for the development of biomarker-based diagnostics, and the growing geriatric population are the key factors projected to boost the market growth over the forecast period. The rising number of COVID-19 cases across the globe and an increasing number of research on the use of biomarkers for facilitating the detection & treatment of COVID-19 will also support market growth. For instance, a novel biomarker-based non-diagnostic screening device was approved by the U.S. FDA in March 2021 called Tiger Tech COVID Plus Monitor. This device is used to identify indicative biomarkers for COVID-19 and other hyperinflammatory & hypercoagulable conditions in individuals aged 5 years and above.

Recent advancements in biomarkers, such as biomarker signatures, are making neurological diseases more treatable. This has resulted in non-invasive testing, faster drug development, and early diagnosis. R&D is leading to the discovery of novel biomarkers. For instance, as per Nature Journal in 2020, vitronectin is a potential biomarker for heart failure diagnosis. Similarly, in 2020, sTNFR2 was revealed as a novel biomarker for the diagnosis of acute adult T-cell leukemia/lymphoma. The market is likely to witness lucrative growth over the forecast period due to such discoveries and technological advancements.

The major companies operating in the global Biomarker Testing Market outlined in the report are:

Agilent Technologies,Roche

Recent Development:

Roche Holding has acquired 42 companies, including 12 in the last 5 years. A total of 10 acquisitions came from private equity firms. It has also divested 2 assets. Roche Holding's largest acquisition to date was in 2009, when it acquired Genentech for $46.8B. Roche Holding has acquired in 9 different US states, and 9 countries. The Company's most targeted sectors include life science (67%) and medical products (13%).

Agilent has acquired 35 companies, including 12 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 7 assets. Agilent's largest acquisition to date was in 2012, when it acquired Dako AS for $2.2B. It's largest disclosed sale occurred in 2005, when it sold Broadcom to KKR for $2.7B. Agilent has acquired in 11 different US states, and 10 countries. The Company's most targeted sectors include test/measurement equipment (24%) and medical products (21%).

Biomarker Testing Market Segments:

Market Segmentation: By Type

Sepsis Biomarkers

Antibiotic Resistance Biomarkers

Traumatic Brain Injury (TBI) Testing Biomarkers

Stroke Testing Biomarkers

Antibiotic Stewardship Biomarkers

Others

Market Segmentation: By Application

Hospital

Diagnostic Center

Others

Regions Are covered by Global Biomarker Testing Market 

For a comprehensive understanding of market dynamics, the Global Biomarker Testing Market is analyzed across key geographies namely: 

North America (United States, Canada, and Mexico) 

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, and Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa).

Explore Full Report with Detailed TOC Here:

https://www.marketintelligencedata.com/reports/4681565/global-biomarker-testing-market-insights-and-forecast-to-2028?mode=Snehal

The study objectives of this report are:

- To study and analyze the Global Biomarker Testing market size (value and volume) by the company, key regions/countries, products and applications, history data from 2016 to 2021, and forecast to 2028.

- To understand the structure of Biomarker Testing by identifying its various sub-segments.

- To share detailed information about the key factors manipulating the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).

- To analyze the report with respect to individual growth trends, future prospects, and their contribution to the total market. 

- To analyze modest developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Buy now Link:

https://www.marketintelligencedata.com/report/purchase/4681565?mode=su?mode=Snehal

Scope of The Biomarker Testing Market Report:

- The report analyses Biomarker Testing by Type Segment.

- The report assesses the Biomarker Testing by End User. 

- The Global Biomarker Testing has been analyzed by Region.

- The key insights of the report have been presented through the frameworks of SWOT and Market Attractiveness charts.

- The attractiveness of the market has been presented by Region, Type and by End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analyzed in the report.

- The report provides a detailed pipeline analysis developed to cure the problem of Biomarker Testing.

- The report tracks competitive developments, strategies, mergers and acquisitions and new product development.

-To take advantage of business owners, tap hard at Biomarker Testing research to get a thorough understanding of current momentum.

- The report presents the analysis of Biomarker Testing for the historical period of 2016-2021 and the forecast period of 2022-2028.

Note: All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain have been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check with the sales team.

Customizable: The Global Biomarker Testing Market

The Global Biomarker Testing Market report may be modified to meet your specific business needs. Because we understand our client's needs, we offer 25% customization to any of our reports without adding additional value to all of our clients.

Thank you for taking the time to read this article… In accordance with the unique needs of your business, we may also design a custom report. Within 24 hours, we'll get in touch with you and assist you with locating the investigative reports.

About Us:

Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us: Irfan Tamboli (Head of Sales) - MARKET INTELLIGENCE DATA

Phone: +1 (704) 266-3234

Mail to: sales@marketintelligencedata.com

This release was published on openPR.